Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

This study has been completed.
Sponsor:
Information provided by:
Inflabloc Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00106314
First received: March 22, 2005
Last updated: October 17, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given